Cancer Stages Explained: What Stage 0 to Stage IV Mean

There are few things as critical in a diagnosis of cancer as the stage number that comes with it. There is a world of difference between Stage 0 and Stage 4 cancer in terms of treatment options, prognosis, and the future. Unfortunately, there is a common confusion about the concept of cancer stages, partly due to the varying meaning of each stage according to the kind of cancer involved and the confusing terminology (TNM categories, Roman numbers, "localized" vs. "distant") used.

This blog explains the concept of cancer staging, its importance, methods of staging, and the general meaning of each stage in order to clarify any possible doubt about this topic.

What Is Cancer Staging?

Cancer staging is the determination of the extent of cancer in the body, specifically the size of the primary tumor and the degree to which it has spread. It is usually done after confirming a diagnosis through biopsy with physical examinations and tests like CT, MRI and PET scans.

Staging matters for three practical reasons:

It helps doctors determine the most appropriate treatment plan.
It provides a general framework for prognosis, though it can't predict any individual's outcome.
It creates a standardized way for doctors worldwide to communicate about a patient's cancer and compare outcomes across large populations.

The TNM Staging System

Most common among the different staging systems that are available is the TNM system which was created by the American Joint Committee on Cancer (AJCC). This involves dividing a cancer into three groups:

T - Tumor: This stage represents the size and degree of spread of the cancer tumor into the nearby tissues and is divided as T1 to T4 - a higher T number means a bigger tumor or more spread.
N - Nodes: This stage tells us whether cancer has spread to the lymph nodes nearby and, if so, how many. These stages range from N0 to N3, with N0 indicating no lymph node involvement and increasing N numbers showing more spread.
M – Metastasis: Indicates whether the disease has metastasized to remote parts of the body. M0 indicates the absence of metastases while M1 refers to cancer that has metastasized to the bones, liver, lungs, or brain.

The above mentioned three values are put together, such as tumor classified as T2N1M0, and assigned a stage numerically, typically denoted by Roman numeral from 0 to IV. Each particular combination of T, N, and M that corresponds to each stage varies according to cancer type, that is why "Stage III" of breast cancer and "Stage III" of lung cancer denote completely different conditions biologically although the stages are the same.

Another important thing that one should know about TNM system is that it undergoes changes from time to time because this system has several editions already.

Not Every Cancer Uses TNM Staging

However, even though the TNM classification is widely used, it isn't always applicable to every kind of cancer type. Since leukemia does not develop any kind of solid tumors, it is classified depending on the results of the analysis of blood and bone marrow. Lymphoma employs its own classification system depending on the affected parts of the body – the regions of lymph nodes involved and if the disease is located below or above the diaphragm. Also, cancers of the female reproductive system are commonly classified according to the FIGO system created by the International Federation of Gynecology and Obstetrics.

Staging Cancer – How Does It Work?

Stage 0: Carcinoma in Situ

Stage 0 is characterized by the presence of abnormal cells that have not spread outside the layer of tissue they originated from – thus, they have not invaded other tissues yet. This stage is usually known as carcinoma in situ. Not all scientists agree on classifying Stage 0 cancer as such since these cells do not have their invasive capabilities yet. Examples include ductal carcinoma in situ (DCIS) in the breast.

Stage I: Early, Localized Cancer

Stage I cancer is localized, meaning it is limited to the one organ from which it originated with no metastasis to any other regions including the lymph nodes. It is the easiest stage of cancer to treat and usually requires only surgery or minimum other treatments.

Stage II and Stage III: Regional Spread

Stage II and Stage III involve the regional spread of the tumor that has become larger and spread either to the lymph nodes or neighboring tissues but has not yet spread to distant parts of the body. The difference between Stage II and Stage III depends on the type of cancer and usually involves the extent of growth of the tumor and the involvement of the lymph nodes.

Stage IV: Distant Metastasis

Stage IV cancer indicates that the cancer cells have spread from their place of origin to distant parts of the body; usually, it is the liver, lungs, bones, or brain according to the type of primary cancer. This stage is also known as metastatic cancer. The most difficult stage to treat is Stage IV, since systemic treatment (whole-body treatment, such as chemotherapy or immunotherapy) takes the forefront in treating cancer rather than localized treatments such as surgery.

Simplified Version: Localized, Regional, Distant

In addition to clinical staging, many cancer registries, such as the National Cancer Institute’s SEER database, employ a simplified three-level approach, rather than a complete TNM staging:

Localized: cancer limited to its initial location
Regional: cancer spread to the neighboring tissue or lymph nodes
Distant: cancer spread to distant body regions

What is interesting about this alternative is that it has one distinct advantage; since the staging criteria remain unchanged through each update of the TNM system, it allows for tracking the survival trends through long time periods, free from any distortions caused by the updates.

Why Stage Matters So Much for Survival

Staging has strong associations with outcomes; however, the numbers may differ significantly for different cancer types. A few examples can demonstrate the strength of the association in question:

Colorectal cancer: five-year relative survival is about 90% for localized, decreases to about 72% for regional, and to about 15% for distant stages.
Lung cancer: five-year survival rate is approximately 65% for localized, but plummets once the disease is already spread to the regional or distant stages. The main problem with lung cancer is that most of the cases get diagnosed when the disease is already spread from the lungs; that is why lung cancer is responsible for the most deaths due to cancer, although it is not the most frequently diagnosed one.
For all cancers, the localized stage patients show much higher survival rate for five years compared to distant stage patients; therefore, cancer screening is performed in order to identify a disease at an early stage.

However, it is important to understand that the statistics provided are population level – it does not predict what would happen to an individual patient because there are other factors that would affect their prognosis independently of the stage of disease including the patient's age, general health condition, tumor biology, and response to treatment.

Staging and Grading Are Two Different Concepts

People often confuse the two concepts of staging and grading because they refer to different things:

Stage determines the extent of cancer spread (size and location)
Grade reflects how the cells of a cancer appear under a microscope and their growth potential and is usually low, intermediate, and high grade.

The cancer can be early-stage but high-grade (small cancer with aggressive looking cells) or late-stage but low-grade (spread more but have low growth potential).

Clinical Stage vs. Pathologic Stage

There are instances where cancer can be staged several times throughout the process of diagnosis and treatment:

• Clinical staging is conducted before any treatment takes place using physical examinations, images, and biopsies.

• Pathologic staging, on the other hand, is conducted after surgery, when the real tumor and lymph nodes removed from the body can be assessed directly. In some instances, this type of staging offers better information than images alone can provide.

Sometimes there is a little difference between the initial clinical staging and the pathologic staging because of the direct assessment of the tissue by surgeons and pathologists.

Restaging: When Cancer Comes Back

When the disease recurs following treatment, restaging may be done to identify the extent of recurrence. Generally, the recurrence is documented separately from the primary staging of the patient (for instance, by adding an "r" before the staging label such as "rStage II") instead of replacing the previous documentation of staging since the primary staging becomes an important factor in outcome and research.

How Staging Helps Patients Understand Their Disease

From the point of view of a patient or a family member, it is important to understand the staging of the cancer not only as medical information but also because it determines:

Why different treatments are used for patients having the same cancer type
Why the emphasis of the doctor is on screening and symptom checking
The meaning of survival rates, usually provided not as one number but separated into stages
Expectations regarding the treatment, whether it will be localized for early stages or systemic for later stages

Conclusion

The purpose of staging is to answer a very simple question; how much cancer is present and where is it? Stages I through IV differ from each other significantly in terms of the clinical situation that they describe, and it is precisely that clinical situation, more than anything else, that determines the choice of treatment and possible outcomes. To know where one's diagnosis is situated in that regard can mean not only clarification, but the very first step to understanding what will happen next.